Shikonin, the active chemical component derived from lithospermum erythrorhizon, has been identified as a novel tumor PKM2 inhibitor and prevents the conformational transition of tetramer to dimer to inhibit cancer cell glycolysis [28]. Here, PKM is linked to cancer.